What is the recommended treatment for allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Allergies

For allergic reactions, epinephrine is the first-line treatment for anaphylaxis, while antihistamines (H1 and H2) and corticosteroids are recommended for less severe allergic reactions or as adjunctive therapy. 1

Treatment Algorithm for Allergic Reactions

Anaphylaxis Management

  • Epinephrine is the first-line treatment for anaphylaxis and should be administered immediately via intramuscular injection in the anterolateral thigh 1, 2
  • For children weighing <25 kg: 0.15 mg epinephrine auto-injector; for those >25 kg through adults: 0.3 mg epinephrine auto-injector 1
  • When using 1:1,000 epinephrine solution: 0.01 mg/kg with maximum dose of 0.5 mg 1
  • Epinephrine doses may need to be repeated every 5-15 minutes if symptoms persist 1

Adjunctive Treatments for Anaphylaxis

  • H1 antihistamines (diphenhydramine 1-2 mg/kg, maximum 50 mg IV or oral) - useful only for relieving itching and urticaria, not for treating respiratory symptoms or shock 1, 3
  • H2 antihistamines (ranitidine 1-2 mg/kg, maximum 75-150 mg oral/IV) - may be used concurrently with H1 antihistamines 1, 3
  • Corticosteroids (prednisone 1 mg/kg, maximum 60-80 mg oral) - primarily used to prevent recurrent or protracted anaphylaxis 1, 3
  • Bronchodilators (albuterol) - for treatment of bronchospasm not responsive to epinephrine 1

Non-Anaphylactic Allergic Reactions Treatment

For Allergic Rhinitis

  • Intranasal corticosteroids are the most effective medication for controlling symptoms of moderate to severe seasonal allergic rhinitis 1
  • For patients who cannot tolerate intranasal corticosteroids, oral antihistamines (particularly second-generation) are recommended 1
  • For moderate to severe seasonal allergic rhinitis in persons aged 12 years or older, the combination of an intranasal corticosteroid and an intranasal antihistamine may be recommended for initial treatment 1

For Mild Allergic Reactions

  • Second-generation (non-sedating) H1 antihistamines like cetirizine, loratadine, or fexofenadine are preferred for daily management due to minimal sedative effects 4, 5
  • Cetirizine has shown faster onset of action (within 1 hour) compared to loratadine (3 hours) in controlled studies 6
  • In children ages 2-6 years with perennial allergic rhinitis, cetirizine has demonstrated greater efficacy than loratadine in relieving symptoms of rhinorrhea, sneezing, nasal obstruction, and nasal pruritus 7

Special Considerations

Allergen Immunotherapy

  • Should be considered when positive test results for specific IgE antibodies correlate with suspected triggers and patient exposure 1
  • Not recommended for patients with negative test results for specific IgE antibodies 1
  • Particularly beneficial for patients whose symptoms are not well controlled by medications or avoidance measures 1

Follow-up Care After Allergic Reactions

  • Education for patient and family on allergen avoidance and early recognition of symptoms 1
  • For anaphylaxis: epinephrine auto-injector prescription (2 doses) with proper training 1
  • Continuation of adjunctive treatment after discharge: H1 antihistamine (diphenhydramine every 6 hours for 2-3 days or non-sedating alternative), H2 antihistamine (ranitidine twice daily for 2-3 days), and corticosteroid (prednisone daily for 2-3 days) 1
  • Follow-up appointment with primary healthcare professional, with consideration for referral to an allergist/immunologist 1

Important Cautions

  • H1 antihistamines should never be used alone for anaphylaxis as they do not relieve stridor, shortness of breath, wheezing, GI symptoms, or shock 1, 3
  • Asthma must be controlled at the time immunotherapy injections are administered 1
  • First-generation H1 antihistamines cause sedation and cognitive impairment which may contribute to decreased awareness of anaphylaxis symptoms 1
  • For patients on beta-blockers who may have reduced response to epinephrine, glucagon should be available as an additional treatment option 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Second-Line Treatment for Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Loratadine: a nonsedating antihistamine with once-daily dosing.

DICP : the annals of pharmacotherapy, 1989

Research

Therapeutic advantages of third generation antihistamines.

Expert opinion on investigational drugs, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.